Literature DB >> 14720007

Management of malignancy-associated pleural effusion: current and future treatment strategies.

Evaldo Marchi1, Lisete R Teixeira, Francisco S Vargas.   

Abstract

Management of recurrent malignant pleural effusion, a common complication of malignancy, poses a challenge to clinicians. Although almost one century has elapsed since the introduction of the pleurodesis procedure, the ideal approach and best agent are still to be defined. Optimally, pleurodesis should be done at the bedside with a minimally invasive procedure, and suitable agents to achieve pleural symphysis should be inexpensive, available worldwide and free of adverse effects. To date, no substance completely fulfills these requirements. Silver nitrate should be considered for pleurodesis because of its low cost and ease of handling. Although talc has been used most frequently to induce pleurodesis, reports of death due to acute respiratory failure have raised concerns about the safety of this agent. Tetracycline, an effective alternative used in the past, is no longer commercially available. This agent has been substituted with derivatives of tetracycline, such as minocycline and doxycycline with success rates similar to those with tetracycline. Several antineoplastic agents have been injected into the pleural space with the aim of producing pleural symphysis, the most representative of this group being bleomycin. Recent knowledge of the molecular mechanisms involved in pleural inflammation has brought into focus new substances, such as transforming growth factor beta and vascular endothelial growth factor, which may be used as pleurodesis agents in the future. Nevertheless, more studies are necessary to better define the potential of these substances in the induction of pleural symphysis.Ideally, a sclerosing agent should be cost-effective, available worldwide and easily administered. Talc will probably stand as the preferred agent to be used for pleurodesis in malignant pleural effusion because of its efficacy, easy manipulation and handling. However, further investigation is necessary to minimize adverse effects related to talc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14720007     DOI: 10.1007/bf03256654

Source DB:  PubMed          Journal:  Am J Respir Med        ISSN: 1175-6365


  4 in total

1.  Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling.

Authors:  Leila Antonangelo; Francisco S Vargas; Lisete R Teixeira; Milena M P Acencio; Marcelo A Costa Vaz; Mário Terra Filho; Evaldo Marchi
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

2.  Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.

Authors:  José Manuel Porcel; Antonieta Salud; Maria Nabal; Manuel Vives; Aureli Esquerda; Francisco Rodríguez-Panadero
Journal:  Support Care Cancer       Date:  2006-01-10       Impact factor: 3.603

3.  Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study.

Authors:  Shahryar Hashemzadeh; Khosrow Hashemzadeh; Kamran Mamaghani; Elnaz Ansari; Raheleh Aligholipour; Samad Ej Golzari; Kamyar Ghabili
Journal:  Daru       Date:  2012-11-26       Impact factor: 3.117

4.  Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin.

Authors:  Rahmatollah Rafiei; Behnam Yazdani; Sayed Milad Ranjbar; Zahra Torabi; Sedigheh Asgary; Somayeh Najafi; Mahtab Keshvari
Journal:  Adv Biomed Res       Date:  2014-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.